Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proprietary Nutritionals Inc. (PNI) is a leading marketer of branded, patented ingredients for the nutraceutical, functional food, and beverage industries. The company specializes in developing and distributing scientifically-backed ingredients such as Celadrin for joint health, Cran-Max for urinary tract support, and Sytrinol for heart health. PNI focuses on providing manufacturers with high-quality, clinically studied components that offer competitive advantages in the global health and wellness market. Following the acquisition of its parent company, Pharmachem Laboratories, by Ashland in 2017, PNI operates as part of Ashland's extensive health and wellness portfolio. The company is recognized for its commitment to clinical research and innovative delivery technologies like Bio-Shield. PNI's products are widely used by major supplement brands to address various therapeutic areas including cardiovascular and musculoskeletal health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proprietary Nutritionals.